During the past decade, Catholic University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catholic University" #1 sponsor was "Catholic University of the Sacred Heart" with 4 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored, "Campus Bio-Medico University" with 1 trials sponsored and "Catholic University, Italy" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catholic University" #1 collaborator was "2ConduCT" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Australian Society for Antimicrobials" with 1 trials as a collaborator, "Azienda Ospedaliera San Giovanni Battista" with 1 trials as a collaborator and "Bambino Gesù Hospital" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Catholic University" are "Acute Myeloid Leukemia" (1 trials), "Aspergillosis" (1 trials), "Bloodstream Infections" (1 trials), "Breast Cancer" (1 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "Catholic University" in a lesser frequency.

Most popular intervention types in "Catholic University" are "Device" (3 trials), "Drug" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "20G ProCore FNB needle" (1 trials), "25G FNA needle" (1 trials), "Calcitriol" (1 trials), "Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)" (1 trials) and "MARS device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Catholic University" are 8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Catholic University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Catholic University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Catholic University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".